pharma
Five-day remdesivir regimen shows promising clinical benefit in COVID-19 patients, Phase 3 data shows
June 2, 2020Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir
Gilead has unveiled eagerly anticipated new Phase 3 data on the addition of its antiviral therapy remdesivir to standard of …
How Big Brother is helping to fight COVID-19
June 1, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, NHS, coronavirus, feeature, pharma, track and trace
Following the unprecedented disruption created by COVID-19, many governments are increasingly looking at using data from contact-tracing apps to help …
First ever benefit-risk analysis is “favourable” for remdesivir as COVID-19 treatment
May 29, 2020Medical Communications, Research and Development COVID-19, DSRU, Gilead, coronavirus, pharma, remdesivir
The UK-based Drug Safety Research Unit (DSRU) has reported its findings from the first ever systematic benefit-risk analysis of Gilead’s …
MSD and Eisai announce meaningful objective response rates for Keytruda+Lenvima combo in two cancer patient populations
May 29, 2020Medical Communications, Research and Development Lenvima, keytruda, pharma
MSD has pulled back the curtain on new data from two trials of its anti-PD-1 immunotherapy Keytruda (pemvbrolizmuab) in combination …
GlaxoSmithKline commits to the production of one billion doses of COVID-19 vaccine adjuvant in 2021
May 28, 2020Manufacturing and Production COVID-19, GSK, coronavirus, pharma, vaccines
GlaxoSmithKline has just come forward to commit to the manufacture and distribution of one billion doses of vaccine adjuvant against …
The June 2020 issue of Pharmafocus is available to read free online now!
May 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Vaccine, coronavirus, data management, pharma, rare disease, treatment access
The latest monthly edition of Pharmafocus, the June 2020 issue, is available to read for free online now! The world remains …
Cleaning staff excluded from GSK’s £1.5k COVID-19 employee bonus
May 26, 2020Manufacturing and Production COVID-19, GSK, coronavirus, pharma
UK pharma giant GlaxoSmithKline has pledged to pay a cash bonus of £1,500 to staff continuing to work during the …
Interim data for Moderna’s COVID-19 vaccine shows glimmers of hope
May 19, 2020Manufacturing and Production, Research and Development COVID-19, Moderna, Vaccine, coronavirus, pharma
Biotech firm Moderna has unveiled interim data from its Phase 1 trial of mRNA-1273, its vaccine against SARS-CoV-2, the virus …
AstraZeneca pledges to manufacture 30m units of Oxford University’s COVID-19 vaccine
May 19, 2020Manufacturing and Production AstraZeneca, COVID-19, UK, Vaccine, coronavirus, pharma
AstraZeneca has provided an update on the partnership it forged with the University of Oxford in late April to push …
New study on COVID-19 immune response shows promise for vaccine development
May 18, 2020Research and Development, Sales and Marketing COVID-19, coronavirus, pharma
Researchers at the labs of Dr Alessandro Sette and Dr Shane Crotty at California’s La Jolla Institute for Immunology have …
Abbott’s COVID-19 test, used at the White House, fails to identify up to 48% of positive cases, study argues
May 15, 2020Medical Communications, Research and Development Abbott, COVID-19, coronavirus, pharma
Abbott’s 13-minute ID NOW COVID-19 testing kits have come under scrutiny after a study from New York University (NYU) revealed …
100% of multiple myeloma patients respond to Janssen’s investigational CAR T therapy, data shows
May 14, 2020Research and Development CAR T, CAR-T, Janssen, multiple myeloma, pharma
Janssen has revealed new Phase1b/2 findings of the efficacy of its investigational B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T cell …
Japan authorises exceptional approval of Gilead’s remdesivir for severe COVID-19
May 12, 2020Manufacturing and Production, Sales and Marketing COVID-19, Gilead, Japan, coronavirus, pharma, remdesivir
Remdesivir, perhaps the leading hope in the race against COVID-19, has secured approval from Japan’s Ministry of Health, Labour and …
What can previous outbreak modeling tell us about the COVID-19 pandemic?
May 11, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Interview, coronavirus, feature, pharma
Dr LaRee Tracy, a lecturer at San Diego State University and Director of Biostatistics at PHASTAR, led a team of …
FDA approval for Tabrecta in metastatic non-small cell lung cancer with METex14
May 7, 2020Sales and Marketing Incyte, Novartis, Tabrecta, pharma
The FDA has awarded marketing authorisation to Novartis for the Oral MET inhibitor Tabrecta (capmatinib) for the first-line treatment of metastatic non-small …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
